Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Siemens Healthineers AGSMMNY -2.49%79 EV-to-FCF is 14.94 as of Jul. 14, 2026, which is 51% below its 10-year median of 30.55. GuruFocus rates SMMNY with a GF Score™ of 79/100 and a GF Value™ of $30.28 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 414 Medical Devices & Instruments companies, Siemens Healthineers AG ranks better than 70.29% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Siemens Healthineers AG's Enterprise Value is $42,197 Mil.
Siemens Healthineers AG's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $2,824 Mil. Therefore, Siemens Healthineers AG's EV-to-FCF for today is 14.94.
The historical rank and industry rank for Siemens Healthineers AG's EV-to-FCF or its related term are showing as below:
SMMNY'
s EV-to-FCF Range Over the Past 10 Years
Min: 14.88 Med: 30.55 Max: 59.18
Current: 14.94
During the past 11 years, the highest EV-to-FCF of Siemens Healthineers AG was 59.18. The lowest was 14.88. And the median was 30.55.
SMMNY's EV-to-FCF is ranked better than 70.29% of 414
companies
in the Medical Devices & Instruments industry
Industry Median: 23.445
vs SMMNY: 14.94
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Siemens Healthineers AG (OTCPK:SMMNY) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Siemens Healthineers AG's PE Ratio (TTM) for today is calculated as:
Siemens Healthineers AG's share price for today is $19.58.
Siemens Healthineers AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.082.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Siemens Healthineers AG's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Siemens Healthineers AG EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Siemens Healthineers AG's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Siemens Healthineers AG's EV-to-FCF falls into.
Siemens Healthineers AG's current Enterprise Value is $42,197 Mil.
Siemens Healthineers AG's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,824 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Siemens Healthineers AG (SMMNY) has a EV-to-FCF of 14.94 as of Jul. 14, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Siemens Healthineers AG and its competitors. This is 51% below median its historical median of 30.55. Over the past decade, Siemens Healthineers AG's EV-to-FCF has ranged from 14.88 to 59.18. According to the industry distribution chart, Siemens Healthineers AG ranks #123 out of 414 companies in the Medical Devices & Instruments industry, placing it in the top 29.7%.
Is Siemens Healthineers AG's EV-to-FCF too high?
Siemens Healthineers AG's current EV-to-FCF of 14.94 is 51% below median its 10-year median of 30.55. Over the past 10 years, this metric has ranged from a low of 14.88 to a high of 59.18. The Medical Devices & Instruments industry median EV-to-FCF is 23.45. Siemens Healthineers AG's value of 14.94 is 36.3% below this industry median. Based on the distribution chart, Siemens Healthineers AG ranks #123 out of 414 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Siemens Healthineers AG has a GF Score™ of 79/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Siemens Healthineers AG's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Siemens Healthineers AG ranks #123 out of 414 companies for EV-to-FCF. This puts Siemens Healthineers AG in the upper half of its industry. The industry median EV-to-FCF is 23.45. Siemens Healthineers AG's value of 14.94 is 36.3% below this benchmark. Historically, Siemens Healthineers AG's own EV-to-FCF has ranged from 14.88 to 59.18 over the past decade. While the company's 10-year median is 30.55 vs. the industry median of 23.45, Siemens Healthineers AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.45, based on 414 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Siemens Healthineers AG's current EV-to-FCF of 14.94 is 36.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Siemens Healthineers AG and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Siemens Healthineers AG's current EV-to-FCF is 14.94, which is 51% below median its own 10-year median of 30.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Siemens Healthineers AG stock overvalued right now?
Based on GuruFocus' analysis, Siemens Healthineers AG (SMMNY) is currently considered Possible Value Trap. The stock's GF Value™ is $30.28, compared to a current price of $19.58 — trading 35.3% below its estimated fair value. The current EV-to-FCF is 14.94, which is 51% below median its 10-year median of 30.55 and 36.3% below the Medical Devices & Instruments industry median of 23.45. Siemens Healthineers AG's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Siemens Healthineers AG (SMMNY), the current EV-to-FCF is 14.94 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Siemens Healthineers AG (SMMNY) Overvalued in 2026?
Based on GuruFocus' analysis, Siemens Healthineers AG stock appears to be undervalued.
The current stock price of $19.58 is trading 35.3% below its estimated GF Value™ of $30.28.
GuruFocus considers Siemens Healthineers AG to be Possible Value Trap.
Key valuation signals for SMMNY:
EV-to-FCF: 14.94 (51% below median its 10-year median of 30.55)
GF Value™: $30.28 vs. price of $19.58 (35.3% below fair value)
Industry Position: 36.3% below the Medical Devices & Instruments median (#123 of 414)
No single metric tells the full story. See the SMMNY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (56% of sales in fiscal 2025) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (18% of sales) offers radiotherapy and other oncology solutions. The diagnostics segment (19%) includes in vitro diagnostics and point-of-care diagnostics. The advanced therapies (now part of precision therapy) segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. The Americas represents 44% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific, including China (11%), the remainder.
79GF Score
Get the complete analysis for SMMNY
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SMMNY has been successfully added to your 
